KRISHGEN is a leading biotech company focusing on the new therapeutic drugs monitoring assays for oncology, diabetes. The ELISA kits are CE marked. ELISA kits for anti-cancer drugs like Adalimumab, Rituxumab, Trastuzumab, Eculizumab and Incretin Mimetics - GLP1 Agonists like Liraglutide, Semaglutide, Exenatide.
With over 1,200 assays, we look to increase our footprint across the world. All our assays are validated for serum/plasma. We also offer unique assays which are for research use only.